Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Systemic Therapy”

92 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 92 results

Not applicableStudy completedNCT04998682
What this trial is testing

Prospective Evaluation of Targeted Axillary Dissection (TAD)

Who this might be right for
Breast Cancer
University of Miami 20
Testing effectiveness (Phase 2)Looking for participantsNCT07104149
What this trial is testing

Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer

Who this might be right for
Female, Age ≥ 18 Years OldNo Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/ImmunotherapyECOG Score of 0-1+6 more
The First Affiliated Hospital of Zhengzhou University 29
Testing effectiveness (Phase 2)WithdrawnNCT02850874
What this trial is testing

HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmsPancreatic Adenocarcinoma
Wake Forest University Health Sciences
Not applicableStudy completedNCT06706466
What this trial is testing

Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Treated with ICI Therapy.

Who this might be right for
Immunotherapy Gastrict CancerInflammation BiomarkersGastric Cancers
Chang-Ming Huang, Prof. 410
Testing effectiveness (Phase 2)Looking for participantsNCT05020860
What this trial is testing

Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmBreast Cancer Female+8 more
Baylor Breast Care Center 185
Large-scale testing (Phase 3)WithdrawnNCT05063513
What this trial is testing

Autologous Stem Cell Transplantation: International Lupus Trial

Who this might be right for
REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
European Society for Blood and Marrow Transplantation
Not applicableNot Yet RecruitingNCT05131893
What this trial is testing

Neoadjuvant Treatment of Breast Cancer

Who this might be right for
Breast Cancer
National Institute of Oncology, Hungary 300
Testing effectiveness (Phase 2)Looking for participantsNCT06831955
What this trial is testing

LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer (TNBC), Early Setting
Universitaire Ziekenhuizen KU Leuven 356
Large-scale testing (Phase 3)Active Not RecruitingNCT05629585
What this trial is testing

Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)

Who this might be right for
Breast Cancer
AstraZeneca 1,174
Not applicableStudy completedNCT04482803
What this trial is testing

Targeted Biopsy of Carbon Nanoparticles Labelled Axillary Node for CN+ Breast Cancer

Who this might be right for
Location and Biopsy of Axillary Lymph Nodes
The First Affiliated Hospital with Nanjing Medical University 159
Not applicableStudy completedNCT05779982
What this trial is testing

SURPASS Retrospective Study

Who this might be right for
Breast CancerBreast MRINeoadjuvant Systemic Therapy+1 more
Gangnam Severance Hospital 500
Large-scale testing (Phase 3)Not Yet RecruitingNCT06899477
What this trial is testing

Pre-Operative Treatment in REseCTable COlon CanceR

Who this might be right for
Colo-rectal CancerColon CancerColon Carcinoma
Dominik Paul Modest 714
Testing effectiveness (Phase 2)WithdrawnNCT00310128
What this trial is testing

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

Who this might be right for
AIDS-related LymphomaAdult Non-Hodgkin's LymphomaAnaplastic Large Cell Lymphoma
AIDS Malignancy Consortium
Large-scale testing (Phase 3)Study completedNCT00268567
What this trial is testing

Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone

Who this might be right for
Nephritis, Lupus
Peking University
Testing effectiveness (Phase 2)Study completedNCT03200002
What this trial is testing

Cyclophosphamide Versus Mycophenolate Mofetil in Lupus Nephritis

Who this might be right for
To Compare the Effects of Mycophenolate Mofetil With Cyclophosphamide in Neplaese Lupus Nephritis Patients
Chitwan Medical College 49
Testing effectiveness (Phase 2)UnknownNCT00954135
What this trial is testing

Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients

Who this might be right for
Breast Cancer
University of Turin, Italy 190
Not applicableNot Yet RecruitingNCT07608445
What this trial is testing

Physiatry-Led Cancer Prehabilitation During Neoadjuvant Systemic Therapy to Improve Function in Stage III-IVA Gynecologic Cancer Patients

Who this might be right for
Malignant Female Reproductive System Neoplasm
City of Hope Medical Center 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT06769919
What this trial is testing

Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer

Who this might be right for
Breast Cancer
Xijing Hospital 340
Not applicableStudy completedNCT07404462
What this trial is testing

Correlation Between Tumor-infiltrating Lymphocytes and Response to Systemic Therapy in Breast Cancer

Who this might be right for
Breast CancerEarly Breast Cancer
Institute of Oncology Ljubljana 171
Not applicableUnknownNCT05206396
What this trial is testing

TIL Relation to pCR After Neoadjuvant Therapy in Breast Cancer Patients

Who this might be right for
Breast Cancer
Ain Shams University 270
Next Page